MS-DUR Evidence-Based DUR Initiative
Welcome
Welcome to the MS-DUR Evidence-Based DUR Initiative web page. The aim of this initiative is to advance the discipline of drug utilization review (DUR) for federal, state, and commercial entities by developing and championing best practices in DUR.
About MS-DUR
The Mississippi Evidence-Based DUR Initiative (MS-DUR) performs the retrospective drug utilization review (DUR) for the Mississippi Division of Medicaid. MS-DUR supports the function of the DUR Board by performing in-depth analyses using pharmacy and medical claims data to encourage evidence-based appropriate use of medications in the Mississippi Medicaid population. MS-DUR reviews claims data and monitors FDA-based safety information to ensure quality care is delivered to Medicaid beneficiaries. Based on activities of the DUR Board and claims reviews, MS-DUR provides educational outreach to health care practitioners on drug therapy to improve prescribing and dispensing practices for Mississippi Division or Medicaid beneficiaries.
What is retrospective drug utilization review (rDUR)?
The rDUR process typically consists of evaluating administrative claims data for:
- Over/under utilization of drugs
- Drug-drug contraindications
- Drug-condition contraindications
- Drug-age contraindications
- Duplicate therapy
- Duration of therapy
- Clinical appropriateness
Education Focus
The MS-DUR is intended to be an information sharing and education-focused entity, not a punitive program. MS-DUR provides information for health care practitioners serving Mississippi Medicaid beneficiaries to assist with the continued evaluation and management of the patient’s medication requirements. The MS-DUR website has resources for providers, including the “Mississippi Medicaid Pharmacy Update” newsletters and special initiatives developed to assist providers in selecting therapy, like the “Medicaid Cough and Cold Quick List”
Contact
Eric L. Pittman, PharmD
Clinical Director
Evidence-Based DUR Initiative
Research Assistant Professor
Center for Pharmaceutical Marketing and Management
The University of Mississippi
Faser Hall 133
Post Office Box 1848
University, Mississippi 38677-1848
Office: 662-915-5948
Fax: 662-915-5262
Email: epittman@olemiss.edu